Menu

Researchers Create Hair-Growing Skin Organoids

The mini-organs reproduce the two cell layers present in mouse skin and the development of hair follicles, providing a potential model for skin and hair research.

Jan 2, 2018
Catherine Offord

A spherical skin organoid showing the generation of multiple cell layers.EUREKALERT, JIYOON LEE AND KARL R. KOEHLER

Researchers at Indiana University have developed the most realistic mouse skin tissue to be grown in a lab to date, according to a study published yesterday (January 2) in Cell Reports. The new mini-organs, or organoids, grow in 3-D culture and produce hair follicles, making them potential models for research into skin development, skin diseases, and hair growth.

To develop the organoids, the Indiana team cultured pluripotent stem cells from mouse skin. Unlike previous approaches, which have generally grown different layers of the skin separately and then combined them later, the researchers grew the stem cells in a specially developed 3-D medium, resulting in the simultaneous development of both the upper and lower layers of skin in a growing ball of cells suspended in culture.

“You can see the organoids with your naked eye,” study coauthor Karl Koehler of the Indiana University School of Medicine says in a statement. “The skin develops as a spherical cyst, and then the hair follicles grow outward in all directions, like dandelion seeds.”

In the process of the research, the team discovered that the early development of this cyst was crucial to later hair follicle development—disrupting the initial organization of dermal cells blocked follicle growth, Koehler says in the press release. “We think that it’s very important that the cells develop together at an early stage to properly form skin and hair follicles.”

The researchers are now hoping to develop a similar model with human cells, which, Koehler says in the statement, “could be potentially a superior model for testing drugs, or looking at things like the development of skin cancers, within an environment that’s more representative of the in vivo microenvironment.” 

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!